A Multicenter, Randomized, Double-blind, Parallel-group Fixed-dose Study of the Effect on Weight of Bifeprunox Versus Risperidone in the Treatment of Outpatients With Schizophrenia.
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2013
At a glance
- Drugs Bifeprunox (Primary) ; Risperidone
- Indications Schizophrenia
- Focus Adverse reactions; Registrational
- Sponsors Wyeth
- 01 Mar 2008 Status changed from suspended to discontinued according to Clinicaltrials.gov record.
- 09 Jan 2008 Status changed from recruiting to suspended.
- 03 Nov 2006 New trial record.